Your browser doesn't support javascript.
loading
Antibiotic use and outcome in patients with negative blood cultures, a new target population for antimicrobial stewardship interventions: A prospective multicentre cohort (NO-BACT).
Girón-Ortega, José Antonio; Fernández-Guerrero, Raquel; de Oca Arjona, Montserrat Montes; Galán-Sanchez, Fátima; Sagastizábal, Galadriel Pellejero; Romea, Elena Morte; de Cueto, Marina; Garcia, Margarita Beltrán; Palacios-Baena, Zaira; Jorge, Silvia Jiménez; Rodríguez-Baño, Jesús; Retamar-Gentil, Pilar.
Afiliação
  • Girón-Ortega JA; Internal Medicine Department, Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Fernández-Guerrero R; Internal Medicine Department, Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • de Oca Arjona MM; Servicio de Medicina Interna, Enfermedades Infecciosas y Cuidados Paliativos, Hospital Universitario Puerta del Mar, Instituto para la Investigación e Innovación Biomédica de Cádiz (INiBICA), Cádiz, Spain.
  • Galán-Sanchez F; Servicio de Microbiología, Hospital Universitario Puerta del Mar, Instituto para la Investigación e Innovación Biomédica de Cádiz (INiBICA), Cádiz, Spain.
  • Sagastizábal GP; Serviciode Enfermedades Infecciosas, Hospital Clínico Lozano Blesa, Zaragoza, Spain; Institutode Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain.
  • Romea EM; Serviciode Enfermedades Infecciosas, Hospital Clínico Lozano Blesa, Zaragoza, Spain; Institutode Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
  • de Cueto M; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain; Departamentos de Medicina y Microbiología, Universidad de Sevilla, Seville, Spain; Institu
  • Garcia MB; Unidad de Farmacia Hospitalaria, Hospital Universitario Virgen Macarena, Seville, Spain.
  • Palacios-Baena Z; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain; Departamentos de Medicina y Microbiología, Universidad de Sevilla, Seville, Spain; Institu
  • Jorge SJ; Research and Clinical Trials Unit, Hospital Universitario Virgen del Rocío, Seville, Spain.
  • Rodríguez-Baño J; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain; Departamentos de Medicina y Microbiología, Universidad de Sevilla, Seville, Spain; Institu
  • Retamar-Gentil P; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain; Departamentos de Medicina y Microbiología, Universidad de Sevilla, Seville, Spain; Institu
J Infect ; 88(2): 95-102, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38036182
OBJECTIVES: To evaluate the appropriateness of antimicrobial treatment and the risk factors for mortality in patients with negative blood cultures (BC), in order to evaluate whether this population would be a suitable target for antimicrobial stewardship (AMS) interventions. METHODS: A multicentre prospective cohort study of patients with negative BC in three Spanish hospitals between October 2018 and July 2019 was performed. The main endpoints were the appropriateness of antimicrobial treatment (evaluated by two investigators according to local guidelines) and 30-day mortality. Cox-regression was performed to estimate the association between variables and 30-day mortality. RESULTS: Of 1011 patients in whom BC was obtained, these were negative in 803 (79%) and were included; 30-day mortality was 9% (70 patients); antibiotic treatment was considered inappropriate in 299 (40%) of 747 patients evaluated at day 2, and in 266 (46%) of 573 at day 5-7. The variables independently associated with increased risk of 30-day mortality were higher age (HR 1.05; 95% CI 1.03-1.07), neoplasia (HR 2.73; 95% CI 1.64-4.56), antibiotic treatment in the 48 h prior to BC extraction (HR 2.06; 95% CI 1.23-3.43) and insufficient antibiotic coverage at day 2 after BC obtainment (HR 2.35; 95% CI 1.39-4.00). Urinary, catheter and biliary sources of infection were associated with lower risk (HR 0.40; 95% CI 0.20-0.81). CONCLUSIONS: Antimicrobial treatment is frequently inappropriate among patients with negative BC; insufficient antibiotic coverage at day 2 was associated with mortality. These results suggest that patients with negative BC are a suitable population for AS interventions. SUMMARY: Antimicrobial treatment in patients with negative blood culture was frequently inappropriate, and inappropriate coverage at day 2 was associated with increased risk of death. These data support the consideration of this population as a potential target for antimicrobial stewardship interventions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Gestão de Antimicrobianos / Antibacterianos Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Gestão de Antimicrobianos / Antibacterianos Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article